Sofinnova Capital VII FCPR 13D/13G Filings for ShockWave Medical, Inc. (SWAV)

Sofinnova Capital VII FCPR 13D and 13G filings for ShockWave Medical, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2020-09-14
3:44 pm
Sale		 2020-08-17 13D ShockWave Medical, Inc.
SWAV		 Sofinnova Capital VII FCPR 1,694,206
4.980%		 -585,623decrease
(-25.69%)		 Filing
2020-08-18
8:31 pm
Sale		 2020-06-01 13D ShockWave Medical, Inc.
SWAV		 Sofinnova Capital VII FCPR 2,279,829
7.160%		 -1,114,377decrease
(-32.83%)		 Filing